Literature DB >> 3004803

The duration of the foot-and-mouth disease virus carrier state in African buffalo (i) in the individual animal and (ii) in a free-living herd.

J B Condy, R S Hedger, C Hamblin, I T Barnett.   

Abstract

The maintenance of a virus depends on a number of factors, including the duration of infectivity and the size of the available host population. In this work, foot-and-mouth disease virus was shown to persist in individual African buffalo (Syncerus caffer) for up to at least five years; thus, the duration of infectivity is more than adequate to cover the normal periods between calving peaks. In a small isolated free-living population which varied from 30 to 100 buffalo, two immunological types of foot-and-mouth disease virus were maintained for at least 24 years and through several generations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004803     DOI: 10.1016/0147-9571(85)90004-9

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  32 in total

1.  Foot and mouth disease and livestock husbandry practices in the Adamawa Province of Cameroon.

Authors:  B M deC Bronsvoort; V N Tanya; R P Kitching; C Nfon; S M Hamman; K L Morgan
Journal:  Trop Anim Health Prod       Date:  2003-12       Impact factor: 1.559

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Patterns, risk factors and characteristics of reported and perceived foot-and-mouth disease (FMD) in Uganda.

Authors:  Chrisostom Ayebazibwe; Kirsten Tjørnehøj; Frank N Mwiine; Vincent B Muwanika; Anna Rose Ademun Okurut; Hans R Siegismund; Soren Alexandersen
Journal:  Trop Anim Health Prod       Date:  2010-06-06       Impact factor: 1.559

4.  Evolutionary analysis of foot-and-mouth disease virus serotype SAT 1 isolates from east Africa suggests two independent introductions from southern Africa.

Authors:  Abraham K Sangula; Graham J Belsham; Vincent B Muwanika; Rasmus Heller; Sheila N Balinda; Charles Masembe; Hans R Siegismund
Journal:  BMC Evol Biol       Date:  2010-11-30       Impact factor: 3.260

5.  Ultrastructural and replicative features of foot-and-mouth disease virus in persistently infected BHK-21 cells.

Authors:  A Donn; M Castagnaro; A I Donaldson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle.

Authors:  F Gebauer; J C de la Torre; I Gomes; M G Mateu; H Barahona; B Tiraboschi; I Bergmann; P A de Mello; E Domingo
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93.

Authors:  W Vosloo; E Kirkbride; R G Bengis; D F Keet; G R Thomson
Journal:  Epidemiol Infect       Date:  1995-02       Impact factor: 2.451

8.  Shifts in the selection-drift balance drive the evolution and epidemiology of foot-and-mouth disease virus.

Authors:  Damien C Tully; Mario A Fares
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

9.  Persistent Infection of African Buffalo (Syncerus caffer) with Foot-and-Mouth Disease Virus: Limited Viral Evolution and No Evidence of Antibody Neutralization Escape.

Authors:  Martí Cortey; Luca Ferretti; Eva Pérez-Martín; Fuquan Zhang; Lin-Mari de Klerk-Lorist; Katherine Scott; Graham Freimanis; Julian Seago; Paolo Ribeca; Louis van Schalkwyk; Nicholas D Juleff; Francois F Maree; Bryan Charleston
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

10.  Genetic characterization of foot-and-mouth disease viruses, Ethiopia, 1981-2007.

Authors:  Gelagay Ayelet; Mana Mahapatra; Esayas Gelaye; Berhe G Egziabher; Tesfaye Rufeal; Mesfin Sahle; Nigel P Ferris; Jemma Wadsworth; Geoffrey H Hutchings; Nick J Knowles
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.